Kimberley Hockley

Recommendations for benefit–risk assessment methodologies and visual representations

Diana Hughes, Ed Waddingham, Shahrul Mt‐Isa et al. · Pharmacoepidemiology and Drug Safety · 2016 · 70 citations · Full text

Pharmacy, Visualization, Decision Analysis +16

A case study using the PrOACT‐URL and BRAT frameworks for structured benefit risk assessment

Richard M. Nixon, Christoph Dierig, Shahrul Mt‐Isa et al. · Biometrical Journal · 2015 · 42 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Quantifying Preferences in Drug Benefit‐Risk Decisions

Tommi Tervonen, Aris Angelis, Kimberley Hockley et al. · Clinical Pharmacology & Therapeutics · 2019 · 24 citations · Full text

Pharmacy, Pharmacoeconomics, Clinical Decision Support +15

Benefit–risk assessment in a post‐market setting: a case study integrating real‐life experience into benefit–risk methodology

Christine E. Hallgreen, Hendrika A. van den Ham, Shahrul Mt‐Isa et al. · Pharmacoepidemiology and Drug Safety · 2014 · 21 citations

Pharmacy, Decision Sciences, Pharmacotherapy +17

IMI-PROTECT benefit-risk grouprecommendations report:recommendations for the methodology andvisualisation techniques to be used in theassessment of benefit and risk of medicines

Diana Hughes, Ed Waddingham, Shahrul Mt‐Isa et al. · London School of Economics and Political Science Research Online (London School of Economics and Political Science) · 2014 · 15 citations

Pharmacy, Pharmaceutical Policy, Pharmacotherapy +14